Nura Bio
Kierstin Ikeda began their work experience as an Administrative Assistant at Opya in June 2015 and ended in August 2019. Kierstin then joined DC3 Therapeutics in May 2020 as a Research Associate and worked until November 2021. Currently, they are employed at Nura Bio, starting as a Research Associate I in November 2021 and then transitioning to a Research Associate II in January 2023.
Kierstin Ikeda attended UC San Diego from 2017 to 2021, where they obtained a Bachelor of Science degree in Biology.
Nura Bio
Nura Bio revolutionizes the treatment of neurological diseases with novel, life-changing neuroprotective medicines. Nura Bio was conceived in 2018 by The Column Group and its scientific founders.